Prevention of Severe Adverse Drug Reaction Outcomes – The Need for Clinical Decision Making Process for Identification of High Risk Patients in Large and Diverse Populations

Ash Genaidy, George Tran and Alan Baldwin
Additional contact information
Alan Baldwin: Health Management, Anthem Inc, USA

JOJ Internal Medicine, 2019, vol. 1, issue 1, 5-14

Abstract: Although severe adverse drug reactions (ADRs) are a major contributor to morbidity/ mortality rates/costs, up to 50% of these adverse events can be prevented. To date, efforts of ADR prevention have relied upon the identification of high risk patients via models used to predict the likelihood of ADR outcomes without being specific about outcome type or the development of clinical rules geared at a limited set of ADRs, predominantly bleeding outcomes.

Keywords: journal of orthopaedics; orthopaedics journals impact factor; orthopaedics articles impact factor; scholarly publishing orthopedics journals; juniper publishers opena ccess orthopedics journal; Rheumatology; rheumatology journals impact factor 2018; rheumatology journals impact factor; rheumatology open access journals; juniper publishers review (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://juniperpublishers.com/jojim/pdf/JOJIM.MS.ID.555552.pdf (application/pdf)
https://juniperpublishers.com/jojim/JOJIM.MS.ID.555552.php (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:adp:jjojim:v:1:y:2019:i:1:p:5-14

DOI: 10.19080/JOJIM.2019.01.555552

Access Statistics for this article

JOJ Internal Medicine is currently edited by Sophia Mathis

More articles in JOJ Internal Medicine from Juniper Publishers Inc.
Bibliographic data for series maintained by Robert Thomas ().